Skin Perfusion Pressure Testing Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, by Mobility and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Skin Perfusion Pressure Testing Devices Market Outlook - 2027

Flow of blood in the skin is considered as an essential parameter in examining the healing potential of the wound. Recently, skin perfusion pressure testing has evolved as precise method to assess the blood flow to the affected tissue. Skin perfusion pressure (SPP) is an essential pressure mandatory for normalizing microcirculatory blood flow prioritizing the release of carefully controlled occlusion. Skin perfusion pressure testing devices are minimally invasive devices in nature utilized in measurement of blood flow rate and evaluate segmental blood pressures, like ankle brachial index (ABI). The skin perfusion pressure devices are extensively implemented in peripheral arterial diseases diagnostics like critical limb ischemia, and in determination of optimal amputation level and others. Usually, 20% of people suffering from critical limb ischemia face unresolved pain or tissue loss, 30% patients develop complications related to amputation within a year of the diagnosis, and around 25% face fatalities in a year. Skin perfusion pressure testing devices provide better prediction in wound healing and offers higher success possibilities to chronic lower extremity patients, along with also expertise in treatment options.

COVID – 19 scenario analysis: 

• The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
• Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
• Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
• Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
• Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to skin perfusion pressure testing devices has been reduced and this segment have to face negligence subsequently causing negative impact on skin perfusion pressure testing devices market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The global skin perfusion pressure testing devices market is driven by key factors such as deep penetrating channels distribution for these devices various end user segments such as hospitals, ambulatory surgical centers providing better access in matured markets, rising demand for latest skin perfusion pressure testing devices along with shifting emphasis of manufacturers on developing superior devices. The skin perfusion pressure being non-invasive diagnosis procedure examining blood flow by quantitative means along with determination of systolic pressure in microcirculation. The skin perfusion pressure testing is increasingly recommended patients suffering from diabetes and peripheral arterial disease (PAD), their surging prevalence would boost the demand for skin perfusion pressure testing devices in market.

Furthermore, usage of skin perfusion pressure testing is attributed with various advantages over traditional techniques to measure blood flow below the skin are contributing to the adoption rate of skin perfusion pressure testing devices and aiding in generating higher sales for major market players. Moreover, unlike ankle brachial index or toe pressure, skin perfusion pressure testing has potential to be used in performing limb measurement that have undergone amputation. Moreover, increasing diabetic population would accelerate the business growth in near future.

On the other hand, the lack of skilled professionals as these devices need trained personnel to obtain precise results in emerging geographies might hinder the market growth to certain extent.

Soaring demand minimally invasive surgical procedures, need for better treatment options and rising burden of peripheral artery diseases (PAD) and limb ischemia contributing factors providing abundant growth opportunities for the skin perfusion pressure testing devices market in East Asian region.

Increasing patient preference toward minimally invasive surgeries

Surging demand for minimally invasive surgeries would have a positive impact on the market, as the incidence rate of various chronic diseases like diabetes and geriatric population has been on rise as well, creating large patient pool. Minimally invasive surgeries are being increasingly popular pertaining benefits for medical personal as well as patients. As a result, there has been a shift in the patient preference towards minimally invasive surgeries owing to certain attributes such as minor incisions, lesser pain, tissue damage, prevention of surgical scars, rapid recovery, lower chances of infection and lesser stay at the healthcare facilities in comparison with invasive surgeries. These techniques are being increasingly used across the medical field as they benefit both the medical professionals and patients as they minimize the discomfort caused to patients due to open surgeries and mostly, avoid surgeries and physical harm. The advantages such as minor complications in rare cases, less pain and lower surgery costs pertaining to use of skin perfusion pressure testing devices is likely to facilitate the market growth over the next few years.

Increasing prevalence of PADs

Increasing prevalence of Peripheral Artery Diseases (PADs) has resulted in rising demand for coronary and vascular intervention in the recent years would propel the atherectomy devices market in the coming years. , there has been tremendous growth in prevalence of PAD with almost 24% and is growing exponentially. The under-developed economies, witnessed 29% growth, whereas developed economies accounted for 13% growth, in the last decade.  In the U.S. alone, there are around 16 million diabetic patients with 15% of these patients eventually progressing toward foot ulcers resulting in inevitable limb amputation. Additionally, increasing incidences of diabetes, cardiovascular diseases as well as critical limb ischemia in the recent years, in elderly as well as younger generations would soar the demand for skin perfusion pressure testing devices and simultaneously estimated to rise at tremendous rate in the coming years.

Key benefits of the report:

• This study presents the analytical depiction of the global skin perfusion pressure testing devices industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global skin perfusion pressure testing devices market share.
• The current market is quantitatively analyzed to highlight the global skin perfusion pressure testing devices market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global skin perfusion pressure testing devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Skin Perfusion Pressure Testing Devices Market research report:

• What are the leading market players active in the skin perfusion pressure testing devices market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

  Skin Perfusion Pressure Testing Devices Market Report Highlights

Aspects	Details
By Product	Ultrasound skin perfusion pressure testing devices Laser doppler skin perfusion pressure testing devices Photoplethysmography skin perfusion pressure testing devices
By Mobility	Cart-based devices Portable devices
By End User	Hospitals Ambulatory Surgical Centers Diagnostic Centers Others
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, Italy, Uk, Spain, Rest of Europe) Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	BIOPAC Systems Inc., Moor Instruments, ELCAT, ADInstruments, Promed Group, Viasonix., Vasamed, Perimed, CorVascular Diagnostics, Koven Technology
Other Players	Johnson and Johnson

^*Terms and Conditions Apply